Goncalves, J., Santos, M., Acurcio, R., Iria, I., Gouveia, L., Matos Brito, P., Catarina Cunha‐Santos, A., Barbas, A., Galvão, J., Barbosa, I., Aires da Silva, F., Alcobia, A., Cavaco, M., Cardoso, M., Delgado Alves, J., Carey, J. J., Dörner, T., Eurico Fonseca, J., Palmela, C., Torres, J., Lima Vieira, C., Trabuco, D., Fiorino, G., Strik, A., Yavzori, M., Rosa, I., Correia, L., Magro, F., D'Haens, G., Ben‐Horin, S., Lakatos, P. L., & Danese, S. (2018). antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition. Alimentary pharmacology & therapeutics, 48(5), 507–522. http://access.bl.uk/ark:/81055/vdc_100093491530.0x00004b